Pharmaceutical Technology4 小时
Utidelone by BioStar Pharmaceuticals for Soft Tissue Sarcoma: Likelihood of Approval
Utidelone is under clinical development by BioStar Pharmaceuticals and currently in Phase I for Soft Tissue Sarcoma.